awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33829265-3E48BB5A-DD29-4042-8BF8-D6BFD848C668
Q33829265-3E48BB5A-DD29-4042-8BF8-D6BFD848C668
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33829265-3E48BB5A-DD29-4042-8BF8-D6BFD848C668
Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma.
P2860
Q33829265-3E48BB5A-DD29-4042-8BF8-D6BFD848C668
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33829265-3E48BB5A-DD29-4042-8BF8-D6BFD848C668
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36309d88abdf6ce43ab0c14f8e5c92b8be1ed8ff
P2860
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.